308 related articles for article (PubMed ID: 15042895)
1. [The role of cost analysis in the evaluation of the development of medical technology. The case of allogenic stem-cell transplantation].
Groot MT; van Agthoven M; Löwenberg B; Willemze R; Uyl-de Groot CA
Ned Tijdschr Geneeskd; 2004 Mar; 148(10):480-4. PubMed ID: 15042895
[TBL] [Abstract][Full Text] [Related]
2. Cost analysis of HLA-identical sibling and voluntary unrelated allogeneic bone marrow and peripheral blood stem cell transplantation in adults with acute myelocytic leukaemia or acute lymphoblastic leukaemia.
van Agthoven M; Groot MT; Verdonck LF; Löwenberg B; Schattenberg AV; Oudshoorn M; Hagenbeek A; Cornelissen JJ; Uyl-de Groot CA; Willemze R
Bone Marrow Transplant; 2002 Aug; 30(4):243-51. PubMed ID: 12203141
[TBL] [Abstract][Full Text] [Related]
3. Cost analysis of hematopoietic stem cell transplantation in adult patients with acute myeloid leukemia at King Chulalongkorn Memorial Hospital.
Ngamkiatphaisan S; Sriratanaban J; Kamolratanakul P; Intragumtornchai T; Noppakun N; Jongudomsuk P
J Med Assoc Thai; 2007 Dec; 90(12):2565-73. PubMed ID: 18386705
[TBL] [Abstract][Full Text] [Related]
4. Cost utility of allogeneic stem cell transplantation with matched unrelated donor versus treatment with imatinib for adult patients with newly diagnosed chronic myeloid leukaemia.
Breitscheidel L
J Med Econ; 2008; 11(4):571-84. PubMed ID: 19450068
[TBL] [Abstract][Full Text] [Related]
5. Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission.
Kiehl MG; Kraut L; Schwerdtfeger R; Hertenstein B; Remberger M; Kroeger N; Stelljes M; Bornhaeuser M; Martin H; Scheid C; Ganser A; Zander AR; Kienast J; Ehninger G; Hoelzer D; Diehl V; Fauser AA; Ringden O
J Clin Oncol; 2004 Jul; 22(14):2816-25. PubMed ID: 15254049
[TBL] [Abstract][Full Text] [Related]
6. [Hematopoietic stem cell transplantation for treatment of acute leukemia].
Harada M
Gan To Kagaku Ryoho; 1999 Sep; 26(10):1387-95. PubMed ID: 10500524
[TBL] [Abstract][Full Text] [Related]
7. [Costs of autologous bone marrow transplantation in non-Hodgkin lymphoma and acute leukemia].
Uyl-de Groot CA; Rutten FF
Ned Tijdschr Geneeskd; 1994 Jan; 138(1):28-31. PubMed ID: 8289955
[TBL] [Abstract][Full Text] [Related]
8. [Hematopoietic stem cell transplantation for children with cancer].
Ohira M
Gan To Kagaku Ryoho; 1997 Apr; 24(6):644-9. PubMed ID: 9126299
[TBL] [Abstract][Full Text] [Related]
9. Do minitransplants have minicosts? A cost comparison between myeloablative and nonmyeloablative allogeneic stem cell transplant in patients with acute myeloid leukemia.
Cordonnier C; Maury S; Esperou H; Pautas C; Beaune J; Rodet M; Lagrange JL; Rouard H; Beaumont JL; Bassompierre F; Glückman E; Kuentz M; Durand-Zaleski I
Bone Marrow Transplant; 2005 Oct; 36(7):649-54. PubMed ID: 16044135
[TBL] [Abstract][Full Text] [Related]
10. Comparative cost of allogeneic or autologous bone marrow transplantation and chemotherapy in patients with acute myeloid leukaemia in first remission.
Dufoir T; Saux MC; Terraza B; Marit G; Guessard S; Foulon G; Reiffers J
Bone Marrow Transplant; 1992 Oct; 10(4):323-9. PubMed ID: 1422487
[TBL] [Abstract][Full Text] [Related]
11. Disease- or therapy-related bone marrow damage cannot be overcome by changes in stem cell source or dose in allogeneic transplantation.
Novotny JR; Rosenthal C; Elmaagacli AH; Dürig J; Beelen DW; Dührsen U
Eur J Haematol; 2004 Jul; 73(1):1-9. PubMed ID: 15182331
[TBL] [Abstract][Full Text] [Related]
12. Comparative cost analysis of autologous peripheral blood progenitor cell and bone marrow transplantation in pediatric patients with malignancies.
Vicent MG; Madero L; Chamorro L; Madero R; Diaz MA
Haematologica; 2001 Oct; 86(10):1087-94. PubMed ID: 11602415
[TBL] [Abstract][Full Text] [Related]
13. Fludarabine and cytarabine combined chemotherapy followed by transfusion of donor blood stem cells for treating relapse of acute leukaemia after allogeneic haematopoietic stem cell transplantation.
You Y; Li QB; Chen ZC; Li WM; Xia LH; Zhou H; Zou P
Chin Med J (Engl); 2008 Sep; 121(18):1770-4. PubMed ID: 19080355
[TBL] [Abstract][Full Text] [Related]
14. Real-world costs of autologous and allogeneic stem cell transplantations for haematological diseases: a multicentre study.
Blommestein HM; Verelst SG; Huijgens PC; Blijlevens NM; Cornelissen JJ; Uyl-de Groot CA
Ann Hematol; 2012 Dec; 91(12):1945-52. PubMed ID: 22864761
[TBL] [Abstract][Full Text] [Related]
15. Valuing clinical strategies early in development: a cost analysis of allogeneic peripheral blood stem cell transplantation.
Bennett C; Waters T; Stinson T; Almagor O; Pavletic Z; Tarantolo S; Bishop M
Bone Marrow Transplant; 1999 Sep; 24(5):555-60. PubMed ID: 10482942
[TBL] [Abstract][Full Text] [Related]
16. Autologous and allogeneic stem cell transplantation in adult ALL: the Swedish Adult ALL Group experience.
Hallböök H; Hägglund H; Stockelberg D; Nilsson PG; Karlsson K; Björkholm M; Linderholm M; Wahlin A; Linder O; Smedmyr B;
Bone Marrow Transplant; 2005 Jun; 35(12):1141-8. PubMed ID: 15834433
[TBL] [Abstract][Full Text] [Related]
17. Treatment of relapsed acute leukemia after allogeneic transplantation: a single center experience.
Arellano ML; Langston A; Winton E; Flowers CR; Waller EK
Biol Blood Marrow Transplant; 2007 Jan; 13(1):116-23. PubMed ID: 17222760
[TBL] [Abstract][Full Text] [Related]
18. A prospective cost evaluation related to allogeneic haemopoietic stem cell transplantation including pretransplant procedures, transplantation and 1 year follow-up procedures.
Mishra V; Vaaler S; Brinch L
Bone Marrow Transplant; 2001 Dec; 28(12):1111-6. PubMed ID: 11803351
[TBL] [Abstract][Full Text] [Related]
19. A detailed analysis of charges for hematopoietic stem cell transplantation at a children's hospital.
Kline RM; Meiman S; Tarantino MD; Herzig RH; Bertolone SJ
Bone Marrow Transplant; 1998 Jan; 21(2):195-203. PubMed ID: 9489638
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic stem-cell transplantation in patients with refractory acute leukemia: a long-term follow-up.
Oyekunle AA; Kröger N; Zabelina T; Ayuk F; Schieder H; Renges H; Fehse N; Waschke O; Fehse B; Kabisch H; Zander AR
Bone Marrow Transplant; 2006 Jan; 37(1):45-50. PubMed ID: 16258531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
